BEIKE BIOTECHNOLOGY CO. LTD.

In News

Generation of human chemically induced pluripotent stem cells from UC-MSCs - Springer Nature Link

Springer Nature Link - Jul 01, 2026

Deep learning-based in silico labeling for analyzing morphological features of MSCs to predict immunomodulatory capacity - Nature

Nature - Mar 10, 2026

Mesenchymal Stem Cell Therapy Market Report, 2025-2030 - Grand View Research

Grand View Research - Apr 16, 2025

Breakdown of Mesenchymal Stem Cell Clinical Trials, by Phase, Geography, Sponsors, and More - BioInformant

BioInformant - Jul 03, 2018

Oryzenin Market Size, Share | CAGR of 12.0% - Market.us

Market.us - Nov 25, 2024

CodeLifeAI Founder Dr. Keith Wai-Yeung Kwong Honoured at the 2025 - The National Law Review

The National Law Review - May 14, 2026

Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression - Nature

Nature - Jan 28, 2023

Trade war threat casts long shadow - Times of Malta

Times of Malta - May 05, 2018

Little Keshivan needs your help - The Citizen

The Citizen - Mar 09, 2016

Know How Oryzenin May Double Its Market Size in Years to Come - openPR.com

openPR.com - Jul 11, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment